Cargando…

Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections

Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection have been published. S. halichoeri grows as small...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakir, Salika M., Gill, Rahul, Salberg, Jonathan, Slechta, E. Susan, Feldman, Mark, Fritsche, Thomas, Clarridge, Jill, Sharp, Susan E., Fisher, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084511/
https://www.ncbi.nlm.nih.gov/pubmed/33900169
http://dx.doi.org/10.3201/eid2705.203428
_version_ 1783686167423614976
author Shakir, Salika M.
Gill, Rahul
Salberg, Jonathan
Slechta, E. Susan
Feldman, Mark
Fritsche, Thomas
Clarridge, Jill
Sharp, Susan E.
Fisher, Mark A.
author_facet Shakir, Salika M.
Gill, Rahul
Salberg, Jonathan
Slechta, E. Susan
Feldman, Mark
Fritsche, Thomas
Clarridge, Jill
Sharp, Susan E.
Fisher, Mark A.
author_sort Shakir, Salika M.
collection PubMed
description Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection have been published. S. halichoeri grows as small, white, nonhemolytic colonies and may be strongly catalase-positive on routine blood agar media, which can lead to isolates being misidentified as coagulase-negative staphylococci. S. halichoeri tests positive for Lancefield group B antigen, like S. agalactiae, but can be identified with matrix-assisted laser desorption/ionization time of flight mass spectrometry or partial 16S rRNA sequencing. We describe 3 cases of S. halichoeri bone and joint infections in patients in the United States with underlying health conditions. In addition, we examine the microbiologic characteristics of S. halichoeri and discuss the importance of fully identifying this organism that might otherwise be disregarded as a skin commensal.
format Online
Article
Text
id pubmed-8084511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-80845112021-05-11 Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections Shakir, Salika M. Gill, Rahul Salberg, Jonathan Slechta, E. Susan Feldman, Mark Fritsche, Thomas Clarridge, Jill Sharp, Susan E. Fisher, Mark A. Emerg Infect Dis Synopsis Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection have been published. S. halichoeri grows as small, white, nonhemolytic colonies and may be strongly catalase-positive on routine blood agar media, which can lead to isolates being misidentified as coagulase-negative staphylococci. S. halichoeri tests positive for Lancefield group B antigen, like S. agalactiae, but can be identified with matrix-assisted laser desorption/ionization time of flight mass spectrometry or partial 16S rRNA sequencing. We describe 3 cases of S. halichoeri bone and joint infections in patients in the United States with underlying health conditions. In addition, we examine the microbiologic characteristics of S. halichoeri and discuss the importance of fully identifying this organism that might otherwise be disregarded as a skin commensal. Centers for Disease Control and Prevention 2021-05 /pmc/articles/PMC8084511/ /pubmed/33900169 http://dx.doi.org/10.3201/eid2705.203428 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Shakir, Salika M.
Gill, Rahul
Salberg, Jonathan
Slechta, E. Susan
Feldman, Mark
Fritsche, Thomas
Clarridge, Jill
Sharp, Susan E.
Fisher, Mark A.
Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title_full Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title_fullStr Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title_full_unstemmed Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title_short Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
title_sort clinical laboratory perspective on streptococcus halichoeri, an unusual nonhemolytic, lancefield group b streptococcus causing human infections
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084511/
https://www.ncbi.nlm.nih.gov/pubmed/33900169
http://dx.doi.org/10.3201/eid2705.203428
work_keys_str_mv AT shakirsalikam clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT gillrahul clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT salbergjonathan clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT slechtaesusan clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT feldmanmark clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT fritschethomas clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT clarridgejill clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT sharpsusane clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections
AT fishermarka clinicallaboratoryperspectiveonstreptococcushalichoerianunusualnonhemolyticlancefieldgroupbstreptococcuscausinghumaninfections